Standout Papers

The FDA-approved drug ivermectin inhibits ... 2012 2026 2016 2021 1.4k
  1. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro (2020)
    Leon Caly, Julian Druce et al. Antiviral Research
  2. Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus (2012)
    Kylie M. Wagstaff, Haran Sivakumaran et al. Biochemical Journal
  3. The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer (2020)
    Sundy N.Y. Yang, Sarah C. Atkinson et al. Antiviral Research

Immediate Impact

26 by Nobel laureates 21 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys
2024 StandoutScience
Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging
2022 Standout
2 intermediate papers

Works of David A. Jans being referenced

Towards safe, non-viral therapeutic gene expression in humans
2005
Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines
2000
and 2 more

Author Peers

Author Last Decade Papers Cites
David A. Jans 11100 4408 2915 364 19.0k
Judith M. White 7655 4002 2350 160 16.8k
Philip L. Felgner 13365 2889 4803 217 20.8k
Stephen H. Leppla 14786 2964 6597 296 18.1k
Kunio Nagashima 5877 2313 1388 263 12.0k
Robert H. Silverman 10423 3281 2085 250 22.0k
Kamel Khalili 8374 1846 1853 445 19.5k
Yoshiharu Matsuura 12528 3836 1991 416 26.9k
Gijs R. van den Brink 12519 2525 4728 315 23.6k
Thomas Lehner 4767 1621 1601 371 19.5k
Judy Lieberman 24208 2340 2368 242 34.5k

All Works

Loading papers...

Rankless by CCL
2026